Update on world health organization HIV drug resistance prevention and assessment strategy: 2004-2011

M. R. Jordan, D. E. Bennett, M. A. Wainberg, D. Havlir, S. Hammer, C. Yang, L. Morris, M. Peeters, A. M. Wensing, N. Parkin, J. B. Nachega, A. Phillips, A. De Luca, E. Geng, A. Calmy, E. Raizes, P. Sandstrom, C. P. Archibald, J. Perriëns, C. M. McClureS. Y. Hong, J. H. McMahon, N. Dedes, D. Sutherland, S. Bertagnolio

Research output: Contribution to journalReview article

Abstract

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

Original languageEnglish (US)
Pages (from-to)S245-S249
JournalClinical Infectious Diseases
Volume54
Issue numberSUPPL. 4
DOIs
StatePublished - May 15 2012

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Update on world health organization HIV drug resistance prevention and assessment strategy: 2004-2011'. Together they form a unique fingerprint.

  • Cite this

    Jordan, M. R., Bennett, D. E., Wainberg, M. A., Havlir, D., Hammer, S., Yang, C., Morris, L., Peeters, M., Wensing, A. M., Parkin, N., Nachega, J. B., Phillips, A., De Luca, A., Geng, E., Calmy, A., Raizes, E., Sandstrom, P., Archibald, C. P., Perriëns, J., ... Bertagnolio, S. (2012). Update on world health organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clinical Infectious Diseases, 54(SUPPL. 4), S245-S249. https://doi.org/10.1093/cid/cis206